NCT02174653View on ClinicalTrials.gov

Safety and Intake Effect of EPs® 7630 (an Extract of the Roots of Pelargonium Sidoides)

PHASE3CompletedINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2016

Conditions
Common Cold
Interventions
DRUG

EPs® 7630

20 mg EPs® 7630 film-coated tablets during 4 months Orally intake three times a day (in the morning, midday and evening)

DRUG

Placebo

Control: Placebo film coated tablets during 4 months Orally intake three times a day (in the morning, midday and evening)

Trial Locations (1)

Unknown

Cardiff University, Common Cold Centre, Cardiff School of Biosciences, Cardiff

All Listed Sponsors
lead

Dr. Willmar Schwabe GmbH & Co. KG

INDUSTRY

NCT02174653 - Safety and Intake Effect of EPs® 7630 (an Extract of the Roots of Pelargonium Sidoides) | Biotech Hunter | Biotech Hunter